FDA NDC Directory · JSON-LD · Markdown

Griseofulvin

NDC 0472-0013 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerActavis Pharma, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA065394
Dosage form / routeSUSPENSION · ORAL
Active ingredientsGRISEOFULVIN (125 mg/5mL)
Marketing started20070726
Package count1

External sources

Source: openFDA. Public-domain (CC0).